Fuji, Japan

Tsutomu Abe


Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 90(Granted Patents)


Company Filing History:


Years Active: 1980-1991

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovator Tsutomu Abe: A Pioneer in Gastric Cancer Research

Introduction: Tsutomu Abe is a prominent inventor based in Fuji, Japan, known for his significant contributions to medical science, particularly in the field of gastric cancer research. With a total of six patents to his name, Abe's work focuses on innovations that aim to improve cancer diagnosis and treatment.

Latest Patents: Among Tsutomu Abe's latest patents is a remarkable invention titled "Human Monoclonal Antibody to Antigen of Gastric Cancer and B-cell Line." This invention relates to a human B-cell line capable of producing a human monoclonal antibody against an antigen discovered on gastric cancer cell lines or tissues. The B-cell line is established through the culturing of B-cells from a lymph node obtained from a patient with gastric cancer, alongside a HAT-sensitive B-cell line. Another significant patent, "Method for Producing Human Antibody," describes an effective method for creating antibody-producing hybrid cell lines. This process utilizes an established B cell line as a parent and fuses these B cells to normal, human antibody-producing cells. Importantly, the established B cell line used in this invention is characterized by the presence of immunoglobulin at the cell surface.

Career Highlights: Tsutomu Abe has had a distinguished career, working at notable companies in the pharmaceutical and biotechnology sectors. He has contributed to advancements in medical science through his time at Asahi Kasei Kogyo Kabushiki Kaisha and Asahi Kasei Kabushiki Kaisha, both of which are leading firms in the industry.

Collaborations: Throughout his career, Abe has collaborated with esteemed colleagues, including Akihiko Ikeda and Katsunori Horikoshi. Their joint efforts in research and development have been pivotal in the progress made within the realm of gastric cancer therapeutics.

Conclusion: Tsutomu Abe stands out as an innovative force in cancer research, with a strong portfolio of patents that showcase his dedication to improving cancer treatment methodologies. His ongoing contributions in the field not only emphasize the importance of scientific exploration but also inspire future generations of inventors and researchers aiming to make a difference in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…